ORIC Pharmaceuticals, Inc. Detailed Financials

Full historical quarterly statements

Metric2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Total Revenue00000000
Cost of Goods Sold0320K000304K00
Gross Profit0-320K000-304K00
R&D Expenses31.4M25.9M28.8M30.5M24.6M32.0M31.2M28.9M
Operating Expenses39.6M34.2M36.7M39.1M32.7M39.3M38.3M36.0M
Operating Income-39.6M-34.6M-36.7M-39.1M-32.7M-39.6M-38.3M-36.0M
Other Income / Gains3.9M4.0M4.1M2.7M2.7M3.3M3.8M4.1M
Net Income-35.8M-30.5M-32.6M-36.4M-30.0M-36.3M-34.6M-32.0M
EPS (Diluted)-0.34-0.30-0.33-0.47-0.42-0.51-0.49-0.45
Reported CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Gross Profit Ratio00000000
General And Administrative Expenses8.2M8.7M7.9M8.5M8.1M07.1M7.1M
Selling And Marketing Expenses00000000
Selling General And Administrative Expenses8.2M8.7M7.9M8.5M8.1M7.3M7.1M7.1M
Other Expenses0-320K000000
Cost And Expenses39.6M34.6M36.7M39.1M32.7M39.6M38.3M36.0M
Interest Income00000004.1M
Interest Expense00000000
Depreciation And Amortization270K320K288K310K302K304K270K272K
Ebitda-35.5M-30.2M-32.3M-36.0M-29.7M-36.0M-34.3M-31.7M
Ebitdaratio00000000
Operating Income Ratio00000000
Income Before Tax-35.8M-30.5M-32.6M-36.4M-30.0M-36.3M-34.6M-32.0M
Income Before Tax Ratio00000000
Income Tax Expense00000000
Net Income Ratio00000000
Epsdiluted-0.34-0.30-0.33-0.47-0.42-0.51-0.49-0.45
Weighted Average Shs Out105.5M87.8M99.0M78.1M71.0M70.7M70.5M70.3M
Weighted Average Shs Out Dil105.5M87.8M99.0M78.1M71.0M70.7M70.5M70.3M